Mirum Pharmaceuticals (MIRM) Competitors $41.95 +0.44 (+1.06%) (As of 12:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MIRM vs. RVMD, LNTH, LEGN, NUVL, BPMC, ELAN, CYTK, TGTX, VKTX, and BBIOShould you be buying Mirum Pharmaceuticals stock or one of its competitors? The main competitors of Mirum Pharmaceuticals include Revolution Medicines (RVMD), Lantheus (LNTH), Legend Biotech (LEGN), Nuvalent (NUVL), Blueprint Medicines (BPMC), Elanco Animal Health (ELAN), Cytokinetics (CYTK), TG Therapeutics (TGTX), Viking Therapeutics (VKTX), and BridgeBio Pharma (BBIO). These companies are all part of the "pharmaceutical products" industry. Mirum Pharmaceuticals vs. Revolution Medicines Lantheus Legend Biotech Nuvalent Blueprint Medicines Elanco Animal Health Cytokinetics TG Therapeutics Viking Therapeutics BridgeBio Pharma Mirum Pharmaceuticals (NASDAQ:MIRM) and Revolution Medicines (NASDAQ:RVMD) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Does the media prefer MIRM or RVMD? In the previous week, Revolution Medicines had 5 more articles in the media than Mirum Pharmaceuticals. MarketBeat recorded 8 mentions for Revolution Medicines and 3 mentions for Mirum Pharmaceuticals. Mirum Pharmaceuticals' average media sentiment score of 1.23 beat Revolution Medicines' score of 0.59 indicating that Mirum Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mirum Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revolution Medicines 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor MIRM or RVMD? Mirum Pharmaceuticals received 40 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 75.63% of users gave Revolution Medicines an outperform vote while only 75.58% of users gave Mirum Pharmaceuticals an outperform vote. CompanyUnderperformOutperformMirum PharmaceuticalsOutperform Votes13075.58% Underperform Votes4224.42% Revolution MedicinesOutperform Votes9075.63% Underperform Votes2924.37% Is MIRM or RVMD more profitable? Revolution Medicines has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -31.69%. Revolution Medicines' return on equity of -33.67% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mirum Pharmaceuticals-31.69% -41.22% -14.81% Revolution Medicines N/A -33.67%-30.08% Do analysts recommend MIRM or RVMD? Mirum Pharmaceuticals presently has a consensus target price of $57.10, indicating a potential upside of 35.34%. Revolution Medicines has a consensus target price of $65.82, indicating a potential upside of 49.76%. Given Revolution Medicines' higher possible upside, analysts clearly believe Revolution Medicines is more favorable than Mirum Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Do insiders and institutionals hold more shares of MIRM or RVMD? 94.3% of Revolution Medicines shares are owned by institutional investors. 22.9% of Mirum Pharmaceuticals shares are owned by insiders. Comparatively, 8.0% of Revolution Medicines shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has better earnings and valuation, MIRM or RVMD? Mirum Pharmaceuticals has higher revenue and earnings than Revolution Medicines. Mirum Pharmaceuticals is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMirum Pharmaceuticals$186.37M10.87-$163.41M-$2.02-20.89Revolution Medicines$742K9,963.92-$436.37M-$3.59-12.24 Which has more risk and volatility, MIRM or RVMD? Mirum Pharmaceuticals has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. SummaryRevolution Medicines beats Mirum Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Mirum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRM vs. The Competition Export to ExcelMetricMirum PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.03B$6.61B$5.16B$9.10BDividend YieldN/A2.99%5.12%4.26%P/E Ratio-20.8910.6387.5117.12Price / Sales10.87194.281,136.45119.65Price / CashN/A57.1643.2337.85Price / Book7.925.104.784.77Net Income-$163.41M$151.83M$120.55M$225.50M7 Day Performance-0.47%-1.19%-1.64%-1.29%1 Month Performance-5.68%-4.73%14.04%0.45%1 Year Performance40.63%8.89%28.88%15.38% Mirum Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRMMirum Pharmaceuticals4.0034 of 5 stars$42.19+1.6%$57.10+35.3%+38.4%$2.03B$186.37M-20.89140Positive NewsRVMDRevolution Medicines4.4814 of 5 stars$44.89-0.3%$63.67+41.8%+61.5%$7.55B$11.58M-12.54443LNTHLantheus4.3841 of 5 stars$94.27+1.3%$130.00+37.9%+49.8%$6.55B$1.50B15.42834LEGNLegend Biotech1.5522 of 5 stars$33.83-3.7%$81.54+141.0%-43.0%$6.18B$520.18M-36.971,800NUVLNuvalent2.2009 of 5 stars$86.65-0.2%$112.60+29.9%+15.2%$6.16BN/A-25.0340Positive NewsBPMCBlueprint Medicines2.5534 of 5 stars$95.39+2.4%$122.11+28.0%+1.5%$6.06B$249.38M-44.17640Insider TradeELANElanco Animal Health3.6565 of 5 stars$12.09-0.1%$16.75+38.5%-20.7%$5.98B$4.45B30.259,300CYTKCytokinetics4.1349 of 5 stars$49.17+1.1%$83.93+70.7%+9.6%$5.80B$3.22M-9.04250Analyst ForecastTGTXTG Therapeutics4.3783 of 5 stars$34.78+8.6%$40.67+16.9%+89.4%$5.41B$233.66M-320.17290Analyst DowngradePositive NewsVKTXViking Therapeutics4.299 of 5 stars$48.07+2.2%$106.75+122.1%+122.4%$5.36BN/A-51.5620BBIOBridgeBio Pharma4.6395 of 5 stars$27.86+1.3%$47.69+71.2%-35.5%$5.27B$217.77M-11.63400Positive News Related Companies and Tools Related Companies Revolution Medicines Competitors Lantheus Competitors Legend Biotech Competitors Nuvalent Competitors Blueprint Medicines Competitors Elanco Animal Health Competitors Cytokinetics Competitors TG Therapeutics Competitors Viking Therapeutics Competitors BridgeBio Pharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MIRM) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRM Stock Alerts